<?xml version="1.0" encoding="UTF-8"?>

<rdf:RDF
   xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
   xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
   xmlns="http://purl.org/rss/1.0/"
   xmlns:dc="http://purl.org/dc/elements/1.1/"
   xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
   xmlns:dcterms="http://purl.org/dc/terms/"

>
<channel rdf:about="http://www.citeulike.org/about">
<pubDate>Thu, 21 Aug 2008 04:53:41 BST</pubDate>


	<title>CiteULike: omalbams Fox</title>
	<description>CiteULike: omalbams Fox</description>


	<link>http://www.citeulike.org/user/omalbam/author/Fox</link>
	<dc:publisher>CiteULike.org</dc:publisher>
	<dc:language>en-gb</dc:language>
	<dc:rights>Copyright &#169; 2004-2008 citeulike.org</dc:rights>
	<items>
    <rdf:Seq>
        <rdf:li rdf:resource="http://www.citeulike.org/user/omalbam/article/2400083"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/omalbam/article/2214634"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/omalbam/article/2205736"/>

	</rdf:Seq>
	</items>
	</channel>


<item rdf:about="http://www.citeulike.org/user/omalbam/article/2400083">
    <title>Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial</title>
    <link>http://www.citeulike.org/user/omalbam/article/2400083</link>
    <description>&lt;i&gt;BMJ (14 February 2008), bmj.39474.922025.BE.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;Objective To evaluate the effectiveness of a structured group education programme on biomedical, psychosocial, and lifestyle measures in people with newly diagnosed type 2 diabetes. Design Multicentre cluster randomised controlled trial in primary care with randomisation at practice level. Setting 207 general practices in 13 primary care sites in the United Kingdom. Participants 824 adults (55% men, mean age 59.5 years). Intervention A structured group education programme for six hours delivered in the community by two trained healthcare professional educators compared with usual care. Main outcome measures Haemoglobin A1c levels, blood pressure, weight, blood lipid levels, smoking status, physical activity, quality of life, beliefs about illness, depression, and emotional impact of diabetes at baseline and up to 12 months. Main results Haemoglobin A1c levels at 12 months had decreased by 1.49% in the intervention group compared with 1.21% in the control group. After adjusting for baseline and cluster, the difference was not significant: 0.05% (95% confidence interval 0.10% to 0.20%). The intervention group showed a greater weight loss: 2.98 kg (95% confidence interval 3.54 to 2.41) compared with 1.86 kg (2.44 to 1.28), P=0.027 at 12 months. The odds of not smoking were 3.56 (95% confidence interval 1.11 to 11.45), P=0.033 higher in the intervention group at 12 months. The intervention group showed significantly greater changes in illness belief scores (P=0.001); directions of change were positive indicating greater understanding of diabetes. The intervention group had a lower depression score at 12 months: mean difference was 0.50 (95% confidence interval 0.96 to 0.04); P=0.032. A positive association was found between change in perceived personal responsibility and weight loss at 12 months (=0.12; P=0.008). Conclusion A structured group education programme for patients with newly diagnosed type 2 diabetes resulted in greater improvements in weight loss and smoking cessation and positive improvements in beliefs about illness but no difference in haemoglobin A1c levels up to 12 months after diagnosis. Trial registration Current Controlled Trials ISRCTN17844016 . 10.1136/bmj.39474.922025.BE</description>
    <dc:title>Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial</dc:title>

    <dc:creator>MJ Davies</dc:creator>
    <dc:creator>S Heller</dc:creator>
    <dc:creator>TC Skinner</dc:creator>
    <dc:creator>MJ Campbell</dc:creator>
    <dc:creator>ME Carey</dc:creator>
    <dc:creator>S Cradock</dc:creator>
    <dc:creator>HM Dallosso</dc:creator>
    <dc:creator>H Daly</dc:creator>
    <dc:creator>Y Doherty</dc:creator>
    <dc:creator>S Eaton</dc:creator>
    <dc:creator>C Fox</dc:creator>
    <dc:creator>L Oliver</dc:creator>
    <dc:creator>K Rantell</dc:creator>
    <dc:creator>G Rayman</dc:creator>
    <dc:creator>K Khunti</dc:creator>
    <dc:creator>On</dc:creator>
    <dc:identifier>doi:10.1136/bmj.39474.922025.BE</dc:identifier>
    <dc:source>BMJ (14 February 2008), bmj.39474.922025.BE.</dc:source>
    <dc:date>2008-02-19T20:41:53-00:00</dc:date>
    <prism:publicationYear>2008</prism:publicationYear>
    <prism:publicationName>BMJ</prism:publicationName>
    <prism:startingPage>bmj.39474.922025.BE</prism:startingPage>
    <prism:category>diabetes</prism:category>
    <prism:category>rct</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/omalbam/article/2214634">
    <title>Acute Effect of Poly-gamma-Glutamic Acid on Calcium Absorption in Post-Menopausal Women</title>
    <link>http://www.citeulike.org/user/omalbam/article/2214634</link>
    <description>&lt;i&gt;J Am Coll Nutr, Vol. 26, No. 6. (1 December 2007), pp. 645-649.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;Objective: Poly-gamma-glutamic acid (PGA) increases calcium (Ca) solubility in vitro and in vivo, and is associated with reduced bone loss in post-menopausal Japanese women. This study is the first to examine the effect of PGA on Ca absorption in humans. Methods: A single-blind, randomized, crossover study with a 34 week wash-out was performed to determine the effect of PGA (80.6% glutamic acids) on Ca absorption measured by the double stable isotope method. Twenty-four healthy, non-smoking, postmenopausal women (mean age: 56.4 +/- SE 0.9) were given 200 g of orange juice containing 200 mg Ca as Ca-44 enriched CaCO3, with or without 60 mg of PGA, after an overnight fast. The two tests were separated by 34 weeks. An intravenous injection of Ca-42 (CaCl2 solution) was given 30 min after consuming the drink and a complete urine collection carried out from 2448 h post-dosing. Ca absorption was calculated from the Ca isotope ratios measured by thermal ionization quadrupole mass spectrometry (TIQMS). Results: Mean Ca absorption with PGA was significantly higher (P &#60; 0.01) than without PGA, 39.1 (SE 1.6) % and 34.6 (SE 1.9) %, respectively. The effect of PGA on increasing Ca absorption was more marked in a sub-group of subjects whose baseline Ca absorption (without PGA) was lower than the population mean value. Conclusion: Postmenopausal women who received a single dose of PGA increased their intestinal Ca absorption particularly those individuals with lower basal absorptive capacity.</description>
    <dc:title>Acute Effect of Poly-gamma-Glutamic Acid on Calcium Absorption in Post-Menopausal Women</dc:title>

    <dc:creator>Hiroyuki Tanimoto</dc:creator>
    <dc:creator>Tom Fox</dc:creator>
    <dc:creator>John Eagles</dc:creator>
    <dc:creator>Hitoshi Satoh</dc:creator>
    <dc:creator>Hiroko Nozawa</dc:creator>
    <dc:creator>Atsushi Okiyama</dc:creator>
    <dc:creator>Yasushi Morinaga</dc:creator>
    <dc:creator>Susan Fairweather-Tait</dc:creator>
    <dc:source>J Am Coll Nutr, Vol. 26, No. 6. (1 December 2007), pp. 645-649.</dc:source>
    <dc:date>2008-01-10T14:47:10-00:00</dc:date>
    <prism:publicationYear>2007</prism:publicationYear>
    <prism:publicationName>J Am Coll Nutr</prism:publicationName>
    <prism:volume>26</prism:volume>
    <prism:number>6</prism:number>
    <prism:startingPage>645</prism:startingPage>
    <prism:endingPage>649</prism:endingPage>
    <prism:category>diet</prism:category>
    <prism:category>foodsfunctional</prism:category>
    <prism:category>mineral</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/omalbam/article/2205736">
    <title>Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study.</title>
    <link>http://www.citeulike.org/user/omalbam/article/2205736</link>
    <description>&lt;i&gt;Circulation, Vol. 115, No. 12. (27 March 2007), pp. 1544-1550.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;BACKGROUND: Marked reductions in cardiovascular disease (CVD) morbidity and mortality have occurred in the United States over the last 50 years. We tested the hypothesis that the relative burden of CVD attributable to diabetes mellitus (DM) has increased over the past 5 decades. METHODS AND RESULTS: Participants aged 45 to 64 years from the Framingham Heart Study, who attended examinations in an &#34;early&#34; time period (1952 to 1974), were compared with those who attended examinations in a later time period (1975 to 1998). The risk of CVD events (n=133 among those with and 1093 among those without DM) attributable to DM in the 2 time periods was assessed with Cox proportional hazards models; population attributable risk of DM as a CVD risk factor was calculated for each time period. The age- and sex-adjusted hazard ratio for DM as a CVD risk factor was 3.0 (95% CI, 2.3 to 3.9) in the earlier time period and 2.5 (95% CI, 1.9 to 3.2) in the later time period. The population attributable risk for DM as a CVD risk factor increased from 5.4% (95% CI, 3.8% to 6.9%) in the earlier time period to 8.7% (95% CI, 5.9% to 11.4%) in the later time period (P for attributable risk ratio=0.04), although multivariable adjustment resulted in attenuation of these findings (P=0.12); most of these observations were found among men. CONCLUSIONS: The proportion of CVD attributable to DM has increased over the past 50 years in Framingham. These findings emphasize the need for increased efforts to prevent DM and to aggressively treat and control CVD risk factors among those with DM.</description>
    <dc:title>Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study.</dc:title>

    <dc:creator>CS Fox</dc:creator>
    <dc:creator>S Coady</dc:creator>
    <dc:creator>PD Sorlie</dc:creator>
    <dc:creator>RB D'Agostino</dc:creator>
    <dc:creator>MJ Pencina</dc:creator>
    <dc:creator>RS Vasan</dc:creator>
    <dc:creator>JB Meigs</dc:creator>
    <dc:creator>D Levy</dc:creator>
    <dc:creator>PJ Savage</dc:creator>
    <dc:identifier>doi:10.1161/CIRCULATIONAHA.106.658948</dc:identifier>
    <dc:source>Circulation, Vol. 115, No. 12. (27 March 2007), pp. 1544-1550.</dc:source>
    <dc:date>2008-01-08T00:20:23-00:00</dc:date>
    <prism:publicationYear>2007</prism:publicationYear>
    <prism:publicationName>Circulation</prism:publicationName>
    <prism:issn>1524-4539</prism:issn>
    <prism:volume>115</prism:volume>
    <prism:number>12</prism:number>
    <prism:startingPage>1544</prism:startingPage>
    <prism:endingPage>1550</prism:endingPage>
    <prism:category>chd</prism:category>
    <prism:category>diabetes</prism:category>
    <prism:category>epidemiology</prism:category>
</item>



</rdf:RDF>

